PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Tamanu oil demonstrated wound-healing and skin-regenerating capabilities in rat models, although one study noted significantly lower wound contraction compared to Centella asiatica [PMID: 34597168, 38256935].
Tamanu oil is considered a candidate for treatment due to anti-inflammatory and antimicrobial properties; an emulgel containing tamanu oil reduced scratching frequency and erythema in vivo [PMID: 35069754, 31238752].
Fruit extracts showed cytotoxic effects against MCF-7 breast cancer cells [PMID: 29068745], and xanthones from stem bark showed antiproliferative activity against B-lymphocyte, colon carcinoma, neuroblastoma, and skin carcinoma cells [PMID: 25730799, 25229947].
Calanolide A and other coumarins (costatolide and inophyllum P) act as potent HIV reverse transcriptase inhibitors [PMID: 32214549, 9934455].
Evidence summary
PubMed sources
- 1.PMID: 35069754 (2021) — Potential of Tamanu (Calophyllum inophyllum) Oil for Atopic Dermatitis Treatment. · Evidence-based complementary and alternative medicine : eCAM
- 2.PMID: 21579166 (2010) — 5-Meth-oxy-2,2-dimethyl-6-[(2E)-2-methyl-but-2-eno-yl]-10-phenyl-2H,8H-pyrano[2,3-f]chromen-8-one (calophyllolide). · Acta crystallographica. Section E, Structure reports online
- 3.PMID: 25730799 (2015) — Antiproliferative xanthone derivatives from Calophyllum inophyllum and Calophyllum soulattri. · Pakistan journal of pharmaceutical sciences
- 4.PMID: 18494888 (2002) — Tamanu (Calophyllum inophyllum) - the African, Asian, Polynesian and Pacific Panacea. · International journal of cosmetic science
- 5.PMID: 34597168 (2021)